Please select the option that best describes you:

What is your approach to women with early-stage hormone responsive breast cancer intolerant of AI's who want to remain on endocrine therapy but have contraindications to tamoxifen?  



Answer from: Medical Oncologist at Academic Institution
Sign in or Register to read more